Cargando…
A Retrospective Review to Determine If Children with Sickle Cell Disease Receive Hydroxyurea Monitoring
INTRODUCTION: Sickle cell disease guidelines recommend that patients on hydroxyurea receive monitoring at least every 2–3 months, but it is unknown if this occurs in clinical practice. This study aimed to determine if patients with sickle cell disease at Nationwide Children’s Hospital had at least 4...
Autores principales: | Creary, Susan E., O’Brien, Sarah H., Stanek, Joseph, Hankins, Jane S., Garee, Amy, Ball, Kyle R., Andrews, Tina M., Chisolm, Deena J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5793862/ https://www.ncbi.nlm.nih.gov/pubmed/29399659 http://dx.doi.org/10.1097/pq9.0000000000000024 |
Ejemplares similares
-
Implementing an EMR-based Health-related Social Needs Screen in a Pediatric Hospital System
por: Dolce, Millie, et al.
Publicado: (2022) -
A Quality Initiative to Decrease Time to Antibiotics in Children with Sickle Cell Disease and Fever
por: McKinney, Christopher, et al.
Publicado: (2020) -
Addressing Challenges of Baseline Variability in the Clinical Setting: Lessons from an Emergency Department
por: Berkowitz, Deena, et al.
Publicado: (2019) -
Economic Evaluation: Onsite HSV PCR Capabilities for Pediatric Care
por: Weber, Zachary, et al.
Publicado: (2020) -
A Multidimensional Electronic Hydroxyurea Adherence Intervention for Children With Sickle Cell Disease: Single-Arm Before-After Study
por: Creary, Susan, et al.
Publicado: (2019)